Autopsy report · NCT02447055
Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma
Cause of deathNo reason given
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Early Phase 1
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University, hospital or other
- Conditions
- Multiple Myeloma; Myeloma-Multiple
- Interventions
- Tocilizumab; Melphalan; Fludarabine; Cyclophosphamide; Tacrolimus; Mycophenolate mofetil
- Participants
- 0
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.